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Annotating Transcriptional Effects of Genetic Variants 
in Disease- Relevant Tissue: Transcriptome- Wide Allelic 
Imbalance in Osteoarthritic Cartilage
Wouter den Hollander,1 Irina Pulyakhina,2 Cindy Boer,3 Nils Bomer,1 Ruud van der Breggen,1 
Wibowo Arindrarto,1 Rodrigo Couthino de Almeida,1 Nico Lakenberg,1 Thom Sentner,1 Jeroen F. J. Laros,1  
Peter A. C. ‘t Hoen,4 Eline P. E. Slagboom,1 Rob G. H. H. Nelissen,1 Joyce van Meurs,3 Yolande F. M. Ramos,1  
and Ingrid Meulenbelt1
Objective. Multiple single- nucleotide polymorphisms (SNPs) conferring susceptibility to osteoarthritis (OA) mark 
imbalanced expression of positional genes in articular cartilage, reflected by unequally expressed alleles among het-
erozygotes (allelic imbalance [AI]). We undertook this study to explore the articular cartilage transcriptome from OA 
patients for AI events to identify putative disease- driving genetic variation.
Methods. AI was assessed in 42 preserved and 5 lesioned OA cartilage samples (from the Research Arthritis and 
Articular Cartilage study) for which RNA sequencing data were available. The count fraction of the alternative alleles 
among the alternative and reference alleles together (φ) was determined for heterozygous individuals. A meta- analysis 
was performed to generate a meta- φ and P value for each SNP with a false discovery rate (FDR) correction for mul-
tiple comparisons. To further validate AI events, we explored them as a function of multiple additional OA features.
Results. We observed a total of 2,070 SNPs that consistently marked AI of 1,031 unique genes in articular carti-
lage. Of these genes, 49 were found to be significantly differentially expressed (fold change <0.5 or >2, FDR <0.05) 
between preserved and paired lesioned cartilage, and 18 had previously been reported to confer susceptibility to 
OA and/or related phenotypes. Moreover, we identified notable highly significant AI SNPs in the CRLF1, WWP2, and 
RPS3 genes that were related to multiple OA features.
Conclusion. We present a framework and resulting data set for researchers in the OA research field to probe for 
disease- relevant genetic variation that affects gene expression in pivotal disease- affected tissue. This likely includes 
putative novel compelling OA risk genes such as CRLF1, WWP2, and RPS3.
INTRODUCTION
Due to the increased proportion of elderly persons in the 
human population, osteoarthritis (OA) has become one of the 
major musculoskeletal diseases (1). While all joint tissues have 
been implicated in OA pathology, the disease is characterized 
primarily by progressive degradation and calcification of articular 
cartilage (2). Both gene- targeted research (3–5) and genome- 
wide research (6–9) showed that a multitude of genes are involved 
in the currently irreversible destruction of articular cartilage that 
precedes total joint replacement surgery, which is at present the 
only effective treatment for end- stage OA. In this regard, numer-
ous studies have shown altered regulation of gene expression 
that reflects, attenuates, and/or stimulates OA- mediated cartilage 
degradation (10–13). Moreover, multiple OA risk alleles of single- 
nucleotide polymorphisms (SNPs) were shown to  consistently 
modulate OA pathology by altering transcription of the respec-
tive genes in articular cartilage, commonly referred to as an allelic 
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imbalance (AI) (14–19). Notable recent examples are the genes 
ALDH1A2 (18) and MGP (20). Hence, it is clear that in-cis genetic 
regulation of transcription plays a substantial role in cartilage 
homeostasis and, therefore, in OA pathophysiology.
Despite the evidence for in-cis genetic regulation of transcrip-
tion in OA susceptibility, genome- wide association studies (GWAS) 
have thus far failed to explain the larger part of the hereditary com-
ponent of OA (21). In this regard, a large number of the tested 
SNPs in GWAS likely bear no biologic function in relation to the 
addressed phenotype or disease- relevant tissues (22), resulting in 
massive inflation of possibly biologically irrelevant statistical tests 
and thus the multiple testing correction penalty. Consequently, 
large numbers of SNPs that do bear biologic functionality in the 
context of OA are missed. Furthermore, SNPs that reside within 
linkage disequilibrium (LD) blocks are hard to interpret, as associ-
ation analysis is inherently unable to distinguish disease- relevant 
alleles from merely statistically associated alleles.
In previous studies, we and others have used targeted 
approaches to address AI events of putative as well as estab-
lished OA susceptibility genes (14,16–18,23,24). Given the suc-
cessful identification of the transcriptional consequences of 
multiple OA- associated SNPs, we have aimed to characterize, 
on a transcriptome- wide scale, novel SNPs that tag AI of genes 
expressed in articular cartilage, and we have subsequently identi-
fied those that appear to confer susceptibility to OA. Finally, further 
using the RNA sequencing data set, we ran analyses to identify 
AI genes whose expression was additionally modified with sever-
ity of OA pathophysiology as reflected by differential expression 
between preserved and lesioned OA cartilage.
MATERIALS AND METHODS
Cohorts. Ethical approval for the Research Arthritis and 
Articular Cartilage (RAAK) study was obtained from the med-
ical ethics committee of the Leiden University Medical Center 
(P08.239), and informed consent was obtained from all patients 
included. For the current study, RNA sequencing data were 
available from preserved and lesioned cartilage from 21 patients 
(6 with hip OA and 15 with knee OA), complemented by an addi-
tional 21 preserved samples (from 14 patients with hip OA and 7 
patients with knee OA) and 5 lesioned samples (from 2 patients 
with hip OA and 3 patients with knee OA) (see Supplementary 
Table 1, available on the Arthritis & Rheumatology web site at 
http://onlinelibrary.wiley.com/doi/10.1002/art.40748/abstract). 
For cartilage sampling details, see refs. 19 and 25.
RNA sequencing data. After RNA isolation  (RNeasy 
Mini Kit, RNA integrity number >7; Qiagen), paired- end 100- 
bp RNA library sequencing (Illumina TruSeq RNA Library Prep 
Kit, Illumina HiSeq 2000) resulted in an average of 10  million 
clusters. Reads were aligned using GSNAP (an R package 
within Bioconductor; https://rdrr.io/bioc/gmapR/) against the 
human (hg19) reference genome, while known Dutch SNPs 
(Genome of the Netherlands) were masked to aid in preventing 
potential reference alignment bias. AI events were assessed 
on SNPs called using SNVMix2 with default settings (26) with 
minimum coverage of 25 and at least 10 reads (R) per allele. 
AI is reported as the average fraction (φ) of the alternative 
allele reads (Ralternative) among the total number of reads (Rtotal = 
R alternative + Rreference) at the position of the respective genetic 
 variation per sample (i):
To detect SNPs that robustly mark imbalance, 2 binomial 
tests were performed per heterozygote and per SNP under 
the null hypothesis that the amount of imbalance is either 
greater or smaller than 0.477. A meta- analysis (meta; http://
www.r-project.org/) per SNP among heterozygous individuals 
(null hypothesis median φ = 0.49) was performed to gener-
ate a meta- φ and P value per SNP with a false discovery rate 
(FDR) correction for multiple comparisons. To allow independ-
ent samples in the meta- analysis only, the preserved cartilage 
of each sample pair (n = 21) was used complemented with the 
individual preserved (n = 21) and lesioned (n = 5) OA samples.
Unfortunately, SNVMix2 discards strand specificity. While 
in general this does not pose an issue when annotating the AI 
direction to an effector allele, it does so for A>T, T>A, G>C, 
and C>G SNPs. Therefore, for these SNPs (n = 119) we sup-
plied (see Supplementary Table 2, http://onlinelibrary.wiley.
com/doi/10.1002/art.40748/abstract) minor allele frequencies 
(MAFs) and SNPs in strong LD for GWAS look- ups. Using the 
edgeR package, fragments per gene were used to assess the 
dispersion by quantile- adjusted conditional maximum likeli-
hood (27). Subsequently, differential gene expression analy-
sis was performed pairwise between preserved and lesioned 
samples for which we had RNA of both (n = 21) (Table 1) fol-
lowed by FDR correction. Gene Ontology (GO) term enrich-
ment analysis was performed using the tool DAVID available 
online (28).
Genotype data. Using Illumina HumanOmniExpressExome 
chips, genome- wide genotyping data were constructed for 216 
samples from the RAAK study. SNPs with <95% call rate, Hardy- 
Weinberg equilibrium <10−4, MAF <0.01, or located on the sex 
chromosomes were removed prior to imputation against the 1000 
GenomesV3 March 2012 reference panel (29). We removed SNPs 
for which the imputation quality of 0.4 was not met (12,30).
TaqMan assay. Conventional TaqMan genotyping was per-
formed on both genomic DNA and articular cartilage complemen-
tary DNA (cDNA) (31) from 6 patients (2 females and 4 males) who 
underwent total joint replacement surgery of the knee due to pri-
mary OA. An allele-specific custom TaqMan assay for rs7256319 
휑=
1
n
n∑
i=1
R
i,alternative
R
i,reference
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(ThermoFisher Scientific) was used to quantify the allele ratio in 
cDNA samples. AI of cDNA was normalized against the genomic 
DNA ratio (with an inherent 1:1 allele ratio) as a reference.
RESULTS
Transcriptome- wide discovery of articular car-
tilage AI events. To understand how genetic variation con-
tributes in-cis to transcriptional regulation in articular cartilage 
on a transcriptome- wide scale, we first called heterozygous 
SNPs (dbSNP144) using RNA sequencing data from articular 
cartilage derived from patients who underwent total replace-
ment surgery of either the hip joint (n = 22) or knee joint (n = 25) 
due to primary OA (Table 1; also see Supplementary Table 1, 
http://onlinelibrary.wiley.com/doi/10.1002/art.40748/abstract). 
After filtering by the number of read counts per position 
(Rreference ≥10, Ralternative ≥10, and Rtotal ≥25), selecting for hete-
rozygous SNPs present in at least 2 individuals, removing SNPs 
present in multiple or no distinct transcripts, and discarding 
the HLA locus, we defined φ for 13,853 SNPs as the meas-
ure of imbalance (Figure  1A), which denotes the fraction of 
Ralternative among Rtotal. Possibly due to reference bias, a consid-
erable number of SNPs were marked as allelic imbalanced by 
φ <0.1 or φ >0.9 (n = 418) and were subsequently removed prior 
to further analyses. As such, in Supplementary Table 2 (http:// 
onlinelibrary.wiley.com/doi/10.1002/art.40748/abstract) we show 
AI, defined as φ across all individuals heterozygous for the 
13,435 SNPs.
Subsequently, a meta- analysis among heterozygous individ-
uals of each SNP (null hypothesis: median φ = 0.49) and subse-
quent FDR correction for multiple testing revealed 2,070 SNPs 
that significantly marked AI among 1,031 genes (Figure  1B; 
also see Supplementary Table 3, http://onlinelibrary.wiley.com/
doi/10.1002/art.40748/abstract). To allow unambiguous annota-
tion of the AI direction to a GWAS effector allele, for A>T, T>A, 
G>C, and C>G SNPs with MAFs surrounding 0.50 (n = 119), we 
supplied MAFs and SNPs in strong LD.
Intersection of genes subject to AI with those differ-
entially expressed between preserved and paired OA- 
lesioned cartilage. While articular cartilage genes subject to AI 
due to genetic variation could contribute to OA pathophysiology 
in various ways (e.g., in cartilage development or homeostasis), 
it can be expected that allelic imbalanced genes that additionally 
mark the articular cartilage’s disease state are more likely to con-
tribute to or attenuate disease progression. Therefore, we went 
back to the original expression data and determined differential 
expression in patients for whom paired RNA sequencing data of 
both preserved and OA- lesioned articular cartilage were gener-
ated (6 hip joints and 15 knee joints) (Table 1).
Table 1. Sample characteristics of preserved and lesioned OA articular cartilage in the Research Arthritis and Articular Cartilage 
study*
Tissue type
No. of 
 samples
Age, mean 
± SD years No. of men
No. of 
women
OA articular cartilage
Preserved Lesioned
Preserved–
lesioned 
pairs
Knee 25 69 ± 9 4 21 22 18 15
Hip 22 66 ± 9 5 17 20 8 6
All 47 68 ± 9 9 38 42 26 21
* OA = osteoarthritic. 
Figure 1. Distribution of allelic imbalance (AI) events in articular cartilage. AI is reported as the average fraction (φ) of the alternative allele 
reads among the total number of reads. A, AI was defined for 13,853 called variants after selecting for at least 2 heterozygotes, selecting single- 
nucleotide polymorphisms (SNPs) present in only single genes and removing low counts. B, After filtering by allelic fraction (0.1<φ<0.9) and 
meta false discovery rate <0.05, 2,070 SNPs remained that marked significant AI of 1,031 unique genes.
DEN HOLLANDER ET AL 564       |
Of the 10,468 Ensembl gene identifiers with at least 5 counts 
per million, 137 and 86 were observed to be significantly (FDR 
<0.05) down- regulated (fold change <0.5) and up- regulated (fold 
change >2), respectively, in lesioned cartilage compared to pre-
served cartilage (see Supplementary Figure 1A and Supplemen-
tary Table 4, http://onlinelibrary.wiley.com/doi/10.1002/art.40748/
abstract). As has been shown by microarray studies that have 
used a similar design, subsequent GO term enrichment analy-
sis (see Supplementary Table 5, http://onlinelibrary.wiley.com/
doi/10.1002/art.40748/abstract) revealed significant enrichment 
for inflammatory pathways (e.g., SCUBE1, CFH, and CXCL14) 
(see Supplementary Figures 1B–D, http://onlinelibrary.wiley.com/
doi/10.1002/art.40748/abstract), pathways of response to wound 
healing (e.g., NOTCH3, BMP5, and SERPINE1) (see Supplemen-
tary Figures 1E–G), and joint development–associated pathways 
(e.g., SPP1, MMP3, and COL9A1) (see Supplementary Figures 
1H–J).
Of the 223 differentially expressed genes, 49 were addition-
ally subject to AI, marked by 128 SNPs (see Supplementary Table 
6, http://onlinelibrary.wiley.com/doi/10.1002/art.40748/abstract). 
A notable example was the CRLF1 gene, which was subject to 
highly consistent AI, with the T allele of rs7256319 marking con-
sistently lower expression of CRLF1 compared to the reference 
allele C (φ = 0.29, FDR = 4.02 × 10−21) (Figure 2A). Moreover, as 
shown in Figure 2B, the AI of CRLF1 was confirmed by custom 
TaqMan assay performed in 5 preserved and 5 lesioned articular 
cartilage samples, originating from 6 independent patients who 
underwent total knee replacement surgery. In parallel, expression 
of CRLF1 in the current data set differed significantly between pre-
served and OA- lesioned cartilage, with significant up- regulation 
in OA- affected cartilage (fold change 4.6, FDR = 3.1 × 10−10) 
(Figure 2C).
Cartilage AI SNPs that contribute to OA suscepti-
bility. On the basis of the significant AI SNPs in articular car-
tilage (see Supplementary Table 3, http://onlinelibrary.wiley.com/
doi/10.1002/art.40748/abstract), it is to be expected that these 
SNPs are enriched for those conferring genetic susceptibility to 
OA. Hence, for 173 AI SNPs with FDR <5 × 10−8, not previously 
reported as OA risk genes, we went to the genome- wide associa-
tion catalogs of OA to look for their genetic association signal. We 
used the GWAS meta- analysis for hip OA performed under the 
auspices of the Translational Research in Europe Applied Technol-
ogies in Osteoarthritis (TreatOA) consortium (32) and the GWAS 
meta- analysis on cartilage thickness (measured by the OA endo-
phenotype minimal joint space width [JSW]) (8). Given that the 
entire genome was not being assessed for genetic association, a 
nominal genetic association (P < 0.05) was considered. Moreover, 
we only checked for genetic association when the AI SNP could 
be used directly or when a clear proxy SNP was identified.
As shown in Table 2, we observed multiple AI SNPs conferring 
susceptibility to hip OA and/or minimal JSW. Notable examples in 
Table 2 are the AI SNP rs3133187 in the RPS3 gene conferring 
the most significant susceptibility to hip OA (Figure 3A) and the AI 
SNP rs1052429 in the WWP2 gene associated with minimal JSW 
(Figure 3B). Alternatively, in Supplementary Tables 7 and 8 (http:// 
onlinelibrary.wiley.com/doi/10.1002/art.40748/abstract), we show 
the intersection of the 65 AI SNPs significantly associated with hip 
Figure  2. CRLF1 expression is subject to allelic imbalance (AI) and is modulated in articular cartilage with osteoarthritis (OA)–induced 
destruction. A, AI of rs7256319 in RNA sequencing data set, reported as the average fraction (φ) of the alternative allele reads among the total 
number of reads with 95% confidence interval, showing decreasing expression of CRLF1 transcript of the alternative T allele in preserved and 
lesioned OA cartilage relative to the reference C allele (φ = 0.29, false discovery rate [FDR] = 4.02 × 10−21). Preserved OA cartilage is depicted 
in blue, lesioned OA cartilage in red, and meta- φ (META) in black. B, Replication of AI expression with rs7256319 by TaqMan genotyping in 
6 additional knee samples, confirming the observed lower expression of the alternative allele T relative to the reference allele C of rs7256319 
(T:C ratio = 0.63). Preserved OA cartilage is depicted in blue, lesioned OA cartilage in red, and genomic DNA (used as the reference ratio) in 
black. The meta- φ of genomic DNA, lesioned cartilage complementary DNA (cDNA), and preserved cartilage cDNA is depicted in black, red, 
and blue, respectively. Data are shown as box plots. Each box represents the 25th to 75th percentiles. Lines inside the boxes represent the 
median. Lines outside the boxes represent the 10th and 90th percentiles. In A and B, horizontal dashed lines depict equal ratios of the CRLF1 
rs7256319 alleles. C, Differential expression analyses of CRLF1 showing significantly up- regulated expression in lesioned (red) compared to 
paired preserved (blue) OA articular cartilage (fold change 4.6, FDR- corrected P = 3.1 × 10−10). RAAK = Research Arthritis and Articular Cartilage 
(study). 
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OA in the TreatOA GWAS meta-analysis (FDR <0.05) and the 63 
AI SNPs significantly associated with minimal JSW in the GWAS 
meta-analysis on cartilage thickness (P < 0.05). Among these 
lists we find SNPs in compelling known (MGP, ALDH1A2, FRZB, 
COL11A1, PLEC) and potentially novel (ACAN, MATN, TNC, 
VEGFA, PLOD2) OA risk genes.
Cartilage AI SNPs that contribute to expression 
quantitative trait loci (eQTLs). To provide additional sup-
porting data on the AI findings in the putative OA risk SNPs in 
Table 2, we combined the RNA sequencing data of the genes with 
genome- wide SNP data (Illumina HumanOmniExpressExome) of 
RAAK study samples to extract gene- targeted cartilage eQTLs on 
the basis of 50 samples that were overlapping. Additionally, we 
explored eQTL data of the Genotype- Tissue Expression (GTEx) 
Project. The fact that GTEx data are merely from tissues other 
than those particularly relevant to OA indicates the generalizability 
of the identified AI to other tissues. As shown in Supplementary 
Table 9 (http://onlinelibrary.wiley.com/doi/10.1002/art.40748/
abstract), the GTEx eQTL data largely support (the direction of) 
the identified AI effects also in other tissues.
OA susceptibility SNPs that show AI in cartilage. 
Since identified OA risk SNPs have been demonstrated to fre-
quently confer risk by modifying expression of positional genes 
in-cis, the aforementioned genome- wide AI data set of articular 
cartilage (see Supplementary Table 3, http://onlinelibrary.wiley.
com/doi/10.1002/art.40748/abstract) can function as a data-
base to assess in silico the direction of effect of such identified 
susceptibility SNPs. Hence, we reviewed the literature to intersect 
the list of currently published robust genetic OA association sig-
nals with the identified AI SNPs. We included robustly identified 
susceptibility SNPs and their positional genes associated with 
knee, hand, and hip OA as well as OA- associated phenotypes 
such as minimal JSW and markers of cartilage turnover (soluble 
cartilage oligomeric matrix protein). Of the 46 genes linked to the 
reported OA risk SNPs, 36 genes were detected in our data set 
(i.e., had detectable expression levels in cartilage) and were het-
erozygous carriers of a coding SNP. As shown in Supplementary 
Table 10 (http://onlinelibrary.wiley.com/doi/10.1002/art.40748/
abstract), we found 11 previously identified OA risk genes to 
contain SNPs that mark AI in articular cartilage. Of these, the 
respective risk alleles marked lower expression through AI in 
heterozygotes of FRZB (rs7775), COL11A1 (rs2615977 and 
rs1676486), IGFBP3 (rs788748 through double heterozygotes 
with rs6670), ALDH1A2 (rs3204689), and MGP (rs4764133 in 
LD with rs1800801). For SMAD3, CDCL5, COL12A1, BCAP29, 
PIK3R1, and COMP, AI was detected but not in relation to the 
reported risk alleles.
To provide additional functional data to these previously iden-
tified OA risk genes, level and differential expression data between 
preserved and lesioned OA articular cartilage are depicted in Sup-
plementary Table 11 (http://onlinelibrary.wiley.com/doi/10.1002/
art.40748/abstract). For IGFBP3, PIK3R1, BCAP29, COL12A1, 
FRZB, ALDH1A2, and MGP, significant differential expression (FDR 
<0.05) was observed in addition to AI. Finally, to find supporting 
data on the AI findings in the OA risk SNPs, we combined the RNA 
sequencing data of the OA risk genes with genome- wide asso-
ciation data (Illumina HumanOmniExpressExome) of RAAK study 
samples to extract gene- targeted eQTL data on the basis of 50 
cartilage samples that were overlapping. Additionally, to the eQTL 
data in Supplementary Table 11, we added data from the GTEx 
Project, although from tissues other than those particularly relevant 
to OA. For the OA genes GNL3, FTO, NCOA3, MICAL3, IFRD1, 
IGFBP3, TGFA, and MGP, we found significant eQTL effects (P 
< 0.05) of risk SNPs that substantiated the respective AI effects.
Figure 3. Compelling cartilage- specific allelic imbalance (AI) genes. AI is reported as the average fraction (φ) of the alternative allele reads 
among the total number of reads with 95% confidence interval. A, Significant (P = 4.97 × 10−9) allelic imbalanced expression at rs3133187 with 
the G allele decreasing expression of RPS3 transcript in preserved and lesioned osteoarthritic (OA) cartilage relative to the A allele (meta-φ = 
0.42). The G allele of rs3133187 additionally confers significant association with hip OA (P = 1.1 × 10−3). B, Significant (P = 3.37 × 10−55) allelic 
imbalanced expression at rs1052429 with the A allele increasing expression of WWP2 transcript in preserved and lesioned OA cartilage relative 
to the G allele (meta- φ = 0.56). The A allele of rs1052429, linked to the A allele of rs1566452 (r2 = 0.92, D′ = 1.0), additionally confers significant 
association with reduced minimal joint space width (P = 2.8 × 10−3), resulting in cartilage degeneration or OA. Horizontal dashed lines depict 
equal ratios of alleles. RAAK = Research Arthritis and Articular Cartilage (study).
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DISCUSSION
Our approach in the current study comprises a concept 
framework for complex traits to identify disease- relevant genetic 
variation, as reflected by allele- associated transcription levels in 
cartilage, a pivotal tissue in the disease. We have aimed to pres-
ent the reported observations as a legacy data set for research-
ers in the field to probe for their gene or SNP of interest. Herein, 
we  highlight notable examples. Among our (highly) significant 
AI SNPs we confirmed well- known genes that have previously 
been reported by others to confer robust risk of OA (e.g., MGP, 
ALDH1A2, IGFBP3, and FRZB) (17,33,34). We hypothesize that 
among our (highly) significant AI SNPs and particularly those that 
show additional, differential expression between preserved and 
lesioned OA cartilage (e.g., CRLF1 [Figure 2; also see Supplemen-
tary Table 6, http://onlinelibrary.wiley.com/doi/10.1002/art.40748/
abstract]) or genetic association with OA phenotypes (e.g., WWP2 
and RPS3 [Figure 3 and Table 2; also see Supplementary Tables 
7 and 8, http://onlinelibrary.wiley.com/doi/10.1002/art.40748/
abstract]) are putative novel compelling OA risk genes.
The CRLF1 gene, encoding for cytokine receptor–like fac-
tor 1 protein, harbors the rs7256319 C>T SNP that has marked 
imbalanced expression of its respective alleles in articular carti-
lage, reflected by consistent lower expression of the alternative 
allele T in comparison with the reference allele C among heterozy-
gotes. As was also reported previously (25,35), CRLF1 appeared 
to be significantly up- regulated in lesioned compared to preserved 
OA articular cartilage (fold change 4.6, FDR = 3.1 × 10−10), as 
was its signaling partner CLCF1 (fold change 2.1, FDR = 1.0 × 
10−6), while the protein complex signaling receptor gene CNTFR 
was significantly down- regulated (fold change 0.3, FDR = 1.9 × 
10−8) (see Supplementary Table 3, http://onlinelibrary.wiley.com/
doi/10.1002/art.40748/abstract). Additionally, it was shown by 
Tsuritani et al (35) that up- regulation of the cytokine receptor–like 
factor 1/cardiotrophin- like cytokine complex in ATDC5 cells dis-
rupts cartilage homeostasis and promotes progression of OA by 
enhancing the proliferation of chondrocytes and suppressing the 
production of cartilage matrix. As such, we hypothesize that the 
alternative allele T of rs7256319 in heterozygote carriers may be 
able to mitigate CRLF1/CLCF1 signaling toward ongoing cartilage 
degradation due to primary OA.
Among the notable novel putative OA genes in Table  2 is 
WWP2, which showed (in addition to multiple coding SNPs mark-
ing consistent AI expression of WWP2 in cartilage) significant dif-
ferential expression between preserved and lesioned OA cartilage 
(fold change 0.78, FDR = 0.0053; results not shown) and a signal 
of genetic association with minimal JSW (P = 0.0028) (Figure 3). 
Based on these data, we hypothesize that allele rs1052429 A 
located in WWP2 is an OA susceptibility allele that acts via higher 
expression of WWP2 in cartilage, which is associated with lower 
minimal JSW and thus with degeneration of cartilage. In addition, 
expression of WWP2 was previously shown to be consistently 
modified by methylation at CpG sites (36). The WWP2 protein is a 
member of the Nedd4 family of E3 ligases, which play an impor-
tant role in protein ubiquitination (37). Moreover, the encoded pro-
tein was shown to physically interact with SOX9, thereby affecting 
the transcriptional activity of SOX9 via translocation to the nucleus 
(38).
Similarly, RPS3, encoding ribosomal protein S3, is subject to 
significant AI marked by rs3133187 with the G allele decreasing 
expression of RPS3 transcript in cartilage (FDR = 4.97 × 10−9) and 
significant association with hip OA (P = 1.1 × 10−3).  Ribosomal 
protein S3 is a multifunctional DNA repair endonuclease and ribo-
somal protein, yet its role in inducing apoptosis through activa-
tion of CASP8/CASP3 may be relevant to mention with respect 
to OA (39). It was recently shown by Jeon et al (40) that selec-
tive removal of senescent cells may attenuate the development 
of OA. We hypothesize that decreasing RPS3 expression by the 
OA risk allele G of rs3133187 negatively affects removal of senes-
cent chondrocytes by cytokine- induced apoptosis. Nonetheless, 
functional studies are necessary to verify the exact mechanism by 
which the AI in CRLF1, WWP2, and RPS3 contributes to cartilage 
degeneration in humans. It would be preferable to investigate this 
using human in vitro micromass cultures in which the expression 
of the genes (e.g., by lentiviral induction) is modified in the direc-
tion of the risk alleles as previously found with, for example, GDF5 
(15) or DIO2 (14).
Our RNA sequencing data set consisted of both preserved 
and lesioned OA samples, as well as knee and hip cartilage. Due 
to our focus on significant AI effects across our samples, we have 
ignored possible variation in the AI effects between preserved and 
lesioned OA cartilage or between knee and hip joints. Such var-
iation could arise, e.g., due to local expression of transcription 
factors that exaggerate or attenuate the observed AI. By provid-
ing AI, defined by φ across all individuals heterozygous for any of 
the 13,435 SNPs (see Supplementary Table 2, http://onlinelibrary.
wiley.com/doi/10.1002/art.40748/abstract), possible differences 
in AI for preserved/OA or hip/knee cartilage may be explored. It 
should be mentioned, however, that the current sample size and 
the variable number of heterozygous individuals likely precludes 
a robust statement on either analyses and will require additional 
targeted AI measurements by, for example, TaqMan assay.
By combining reported genetic OA signals with AI SNPs 
that alter transcription of articular cartilage genes in-cis, we also 
had the opportunity to address functionality of OA risk alleles. For 
example, the A allele of rs788748, located upstream of IGFBP3, 
is associated with lower odds of hip OA (41). Given that this SNP 
is not located in an exon, we assessed its potential revelance to 
AI through rs6670 double heterozygotes, which revealed that the 
protective rs788748 A allele marks lower expression of IGFBP3 
compared to the G allele. In addition, significant up- regulation 
of the gene was observed in OA- affected cartilage compared to 
paired preserved cartilage, as well as a similar eQTL effect of the 
rs788748 SNP (see Supplementary Table 9, http://onlinelibrary.
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wiley.com/doi/10.1002/art.40748/abstract), similar to what has 
been reported by others (8). These observations solidify the notion 
of IGFBP3’s role in OA, and we propose that the reported pro-
tective effect of the rs788748 A allele is mediated through lower 
expression of the transcript.
For a selected number of comparable (although gene- 
targeted) studies, we discuss the respective confirmations 
and/or discrepancies. A number of SNPs are known to mark 
AI in articular cartilage, as has been shown by gene- targeted 
approaches. We were able to replicate the earlier observed AI of 
ALDH1A2 (18) and MGP (20) and to a lesser extent that of DIO2 
(14) and GDF5 (42). Furthermore, for rs11177 (GNL3) (16) and 
rs6617 (SPCS1) (16) in our data set, AI was not as obvious as 
previously reported, and we did not observe heterozygotes for 
rs143383 (GDF5) (23) or rs3815148 (HBP1) (24).
For COL11A1, AI was previously thoroughly investigated 
by Raine et al (17) in view of the OA risk SNP rs2615977 (7) 
and the lumbar disc herniation SNP rs1676486 (43). They 
showed that considerable AI of COL11A1 was correlated with 
the lumbar disc herniation risk allele of SNP rs1676486, while 
the observed AI of COL11A1 was not correlated with the OA 
risk allele of SNP rs2615977. The latter result was based on 
the AI effect observed in individuals double heterozygous for 
rs2615977 and rs9659030. As shown in Supplementary Fig-
ure 2 and Supplementary Table 8 (http://onlinelibrary.wiley.
com/doi/10.1002/art.40748/abstract), we observed 2 inde-
pendent COL11A1 SNPs (D′ = 0.2, r2 = 0.01) (44) with highly 
significant meta- φ AI. The first was the abovementioned SNP 
rs9659030 with meta- φ AI of 0.65 (P = 1.2 × 10−25) and the 
second was SNP rs2229783 with meta- φ AI of 0.53 (P = 3.7 × 
10−8). Notably, and in contrast to the results obtained by Raine 
et al (17), the extent and consistency of AI for rs9659030 were 
considerably higher than those for rs2229783 and rs1676486. 
The suggestive evidence of AI of the lumbar disc herniation 
risk allele of SNP rs1676486 as well as the AI of its proxy 
SNP rs2229783 (D′ = 1, r2 = 0.3) confirm that the lumbar disc 
herniation risk allele is likely associated with lower COL11A1 
expression. Moreover, the AI of the noncoding OA risk SNP 
rs2615977, which is not in strong LD with a coding SNP, 
remains unclear. Yet, based on the proxy SNP rs1031820 (D′ = 
0.77, r2 = 0.16), it may be that the OA risk allele of rs2615977 
also acts via lower expression of COL11A1.
Taken together, these confirmations and/or discrepancies 
indicate first and foremost that additional replication to verify AI is 
required to increase confidence in the observed AI (e.g., by better 
preselection on heterozygous samples). Second, it stresses the 
fact that observed AI reflects regulatory properties of the respec-
tive LD block and does not per se identify genetic variation that 
affects respective gene expression levels mechanistically. Further-
more, despite the applied filtering steps and statistics, the list of 
significant AI SNPs potentially contains a number of false posi-
tives, some of which could have originated from alignment bias. 
While future novel alignment and other bioinformatic approaches 
(45) might address these issues from a more fundamental per-
spective, in the present study we have aimed to reduce false-pos-
itive AI SNPs by including multiple filtering steps (0.1<φ<0.9, 
include SNPs with at least 2 heterozygotes, and null hypothesis 
adjustment).
While in canonical GWAS a strict genome- wide signifi-
cance level of 5 × 10−8 is imposed due to the vast amount of 
SNPs that are tested for, we postulate that providing SNPs 
that are more likely to affect expression of genes in-cis in a 
disease- relevant tissue could aid the search for the functional 
susceptibility SNPs and the putative OA risk gene. Neverthe-
less, among the significant AI SNPs, we did not necessarily 
obtain a clear enrichment of putative significant OA risk SNPs; 
among the SNPs for which we had both AI and GWAS data, 
6.7% showed significant association with the OA pheno-
types, while among the significant AI genes (FDR <0.05), 7.2% 
showed significant association with the OA phenotypes. Fur-
ther downstream selection criteria, such as (but not limited to) 
significant differential expression between preserved and OA- 
lesioned cartilage and/or trans- eQTL analysis, will help tailor 
genetic association analyses even more and might attribute 
SNPs to specific disease facets, such as extent of cartilage 
degradation, as we have shown in the present study. Of note, 
inherent to our study design, we might have missed genes 
that affect joint morphology or cartilage integrity during devel-
opment and/or that change expression in healthy cartilage or 
during early- stage OA.
In summary, we present a framework and resulting data 
set for researchers in the OA research field to probe for disease- 
relevant genetic variation that affects gene expression in pivotal 
disease- affected tissue. This likely includes putative novel compel-
ling OA risk genes such as CRLF1, WWP2, and RPS3.
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